Dr. Mark Hyman

And I remember Peter Libby, who you might have heard of, who's basically the editor-in-chief of the main cardiology textbook that all fellows take called Brenwell's Cardiology.

He is chairman of cardiovascular disease at Harvard.

And I said, Peter, why don't you study lifestyle interventions for cardiovascular disease versus just studying medication?

He said, Mark, I know lifestyle works, but I can't get $5 to study lifestyle.

I can get $150 million to study a drug.

And that's funding my department, that's funding my staff, that's funding me.

And it's the reality of how the system is set up.

So you have to understand that there's an inherent bias

This is the one who said you need to have a special place in hell?

So what were you actually saying and what was Zoe and Dr. Kendrick saying that raised that concern and that why was the Mail on Sunday so vocal about criticizing?

Yeah, and the only thing people don't know, Asim, is that when studies are done, they don't have to be published.

So if studies come out that are showing

Not a positive benefit for a particular drug that has to be submitted to the FDA or whatever the equivalent is in the UK, but they don't actually have to be published in a medical journal.

So you're not seeing the full spectrum of what the data show.

You're just saying cherry pick data that shows this massage and twisted, you know, I think it was Mark Twain said there's liars or damn liars and they're statisticians.

And so it's part of the problem with the statin research is that it's not that they're bad or good.

Every drug has a role.

It's a tool.

It's like saying water, is water good or bad?

Well, if you drink too much water, you can die of seizures, but you need water to survive, right?